C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2011
12/01/2011	US20110294871 Lipids, lipid complexes and use thereof
12/01/2011	US20110294869 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
12/01/2011	US20110294867 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
12/01/2011	US20110294748 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	US20110294747 Pegylated mutated clostridium botulinum toxin
12/01/2011	US20110294733 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
12/01/2011	US20110294728 Antiviral Polypeptides
12/01/2011	US20110294722 Antimicrobial peptides
12/01/2011	US20110294721 Antimicrobial peptides
12/01/2011	US20110294702 Template fixed beta-hairpin loop mimetics and their use in phage display
12/01/2011	US20110294697 System for detectng protease
12/01/2011	US20110294226 Survival motor Neurons (SMN) gene: a gene for spinal muscular atrophy
12/01/2011	US20110294219 Use of the foamy virus bet protein for inactivating apobec
12/01/2011	US20110294218 Cd34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
12/01/2011	US20110294217 Dna nicking enzyme from a homing endonuclease that stimulates site-specific gene conversion
12/01/2011	US20110294216 Sulfonylurea-responsive repressor proteins
12/01/2011	US20110294212 Methods of Screening Molecular Libraries and Active Molecules Identified Thereby
12/01/2011	US20110294209 Methods for producing nonadherent avian cell lines
12/01/2011	US20110294204 Expression system
12/01/2011	US20110294193 Viral vectors and methods for producing and using the same
12/01/2011	US20110294191 Increased production of aspartic proteases in filamentous fungal cells
12/01/2011	US20110294182 Botryoccocus braunii Triterpene Synthase Proteins and Nucleic Acid Molecules, and Methods for Their Use
12/01/2011	US20110294170 Pentose Fermentation By a Recombinant Microorganism
12/01/2011	US20110294166 Thermostable enzymes for the hydrolysis of mannan-containing polysaccharides
12/01/2011	US20110294165 Variant humicola grisea cbh1.1
12/01/2011	US20110294164 Variant humicola grisea cbh1.1
12/01/2011	US20110294162 B-7 related nucleic acids and polypeptides useful for immunomodulation
12/01/2011	US20110294156 Novel anti cxcr4 antibodies and their use for the treatment of cancer
12/01/2011	US20110294149 Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110294134 Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer
12/01/2011	US20110294133 Methods for determining the presence or absence of elite event rf-bn1 in brassica plant material
12/01/2011	US20110294126 Kits and methods for assessing oxidative stress
12/01/2011	US20110294114 Optimization of determinants for successful genetic correction of diseases, mediated by hematopoietic stem cells
12/01/2011	US20110293815 Corn plants and seed enhanced for asparagine and protein
12/01/2011	US20110293810 White wheat varieties, and compositions and methods of using the same
12/01/2011	US20110293708 Process for preparing purified nucleic acid and the use thereof
12/01/2011	US20110293704 Priming of an immune response
12/01/2011	US20110293695 Amphoteric liposomes
12/01/2011	US20110293674 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION
12/01/2011	US20110293656 Recombinant mva capable of expressing structural hcv antigens
12/01/2011	US20110293655 Porcine Adenovirus 3-Based PRRSV Vaccines
12/01/2011	US20110293652 Chimeric ospa genes, proteins, and methods of use thereof
12/01/2011	US20110293650 Influenza virus-like particles (vlps) comprising hemagglutinin
12/01/2011	US20110293646 PAN-DR Binding Polypeptides and Uses Thereof
12/01/2011	US20110293645 Wdrpuh epitope peptides and vaccines containing the same
12/01/2011	US20110293628 Pain treatment using erk2 inhibitors
12/01/2011	US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae
12/01/2011	US20110293619 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
12/01/2011	US20110293618 Anti-human clcp1 antibody and use thereof
12/01/2011	US20110293613 Bispecific antibodies
12/01/2011	US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011	US20110293607 Antibody Variants Having Modifications In The Constant Region
12/01/2011	US20110293602 Vegf-like factor antibodies and methods of use thereof
12/01/2011	US20110293601 Composition and method for treatment of reperfusion injury and tissue damage
12/01/2011	US20110293599 Method for modulating muscle differentiation or regeneration
12/01/2011	US20110293587 Glucagon analogues
12/01/2011	US20110293586 Glucagon analogues
12/01/2011	US20110293580 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
12/01/2011	US20110293571 Method for vector delivery
12/01/2011	US20110293567 Use of bacteria for the sensing and killing of cancer cells
12/01/2011	US20110293566 Diffocin and methods of use thereof
12/01/2011	US20110293557 Conjugates for the administration of biologically active compounds
12/01/2011	CA2804119A1 Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same
12/01/2011	CA2801913A1 Tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains
12/01/2011	CA2801057A1 Tailored oils produced from recombinant heterotrophic microorganisms
12/01/2011	CA2800852A1 Protein body-inducing polypeptide sequences
12/01/2011	CA2800759A1 Method for increasing plant biomass
12/01/2011	CA2800744A1 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	CA2800728A1 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
12/01/2011	CA2800688A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	CA2800671A1 Modified beta-lactamases and methods and uses related thereto
12/01/2011	CA2800600A1 Process and microorganisms for production of lipids
12/01/2011	CA2800511A1 Diffocins and methods of use thereof
12/01/2011	CA2800412A1 Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions
12/01/2011	CA2799596A1 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra
12/01/2011	CA2799207A1 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
12/01/2011	CA2798937A1 Pentose fermentation by a recombinant microorganism
11/2011
11/30/2011	EP2390803A1 Methods, systems, and software for identifying functional biomolecules
11/30/2011	EP2390340A2 vector encoding Papillomavirus E1 and E2 polypeptides with reduced percentage of identity
11/30/2011	EP2390339A1 Delta-8 desaturases and their use in making polyunsaturated fatty acids
11/30/2011	EP2390338A1 Delta-8 desaturases and their use in making polyunsaturated fatty acids
11/30/2011	EP2390337A1 Plant transformation without selection
11/30/2011	EP2390336A2 Transgenic plants with increased stress tolerance and yield
11/30/2011	EP2390335A2 Polynucleotide markers
11/30/2011	EP2390334A2 Expression system
11/30/2011	EP2390333A1 Polypeptides comprising a modified human serum albumin secretion pre-sequence with improved secretion yield
11/30/2011	EP2390332A1 Cloning and exploitation of a functional R-gene from Solanum x edinense
11/30/2011	EP2390331A1 MicroRNA molecules
11/30/2011	EP2390330A1 MicroRNA molecules
11/30/2011	EP2390329A1 MicroRNA molecules
11/30/2011	EP2390328A1 MicroRNA molecules
11/30/2011	EP2390327A1 siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
11/30/2011	EP2390326A1 Process of producing human type II collagen
11/30/2011	EP2390325A1 Flavonoid-3-glucuronyltransferase and polynucleotide encoding same
11/30/2011	EP2390324A1 CONSTRUCTION OF PROTEIN-RESPONSIVE shRNA/RNAi REGULATION SYSTEM UTILIZING RNP MOTIF
11/30/2011	EP2390322A1 Method for producing recombinant stem bromelain
11/30/2011	EP2390315A1 High fidelity restriction endonucleases
11/30/2011	EP2390313A1 New vegetable acyltransferases specifically for long-chain polyunsaturated fatty acids
11/30/2011	EP2390308A1 Minicell compositions and methods

1 ... 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 ... 4023